We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

183 hedge funds and large institutions have $1.82B invested in Prestige Consumer Healthcare in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 68 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

27% more capital invested

Capital invested by funds: $1.43B → $1.82B (+$391M)

9% more funds holding

Funds holding: 168183 (+15)

2.36% more ownership

Funds ownership: 101.43%103.79% (+2.4%)

4% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 68

Holders
183
Holders Change
+15
Holders Change %
+8.93%
% of All Funds
5.26%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
32
Increased
65
Reduced
68
Closed
17
Calls
$1.41M
Puts
Net Calls
+$1.41M
Net Calls Change
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
KeyBank National Association
126
KeyBank National Association
Ohio
$724K -$6.89K -215 -1%
AQR Capital Management
127
AQR Capital Management
Connecticut
$720K -$1.36M -42,509 -67%
UBS AM
128
UBS AM
Illinois
$701K
GC
129
Globeflex Capital
California
$699K +$661K +20,640 New
CAM
130
Cortina Asset Management
Wisconsin
$690K +$56.6K +1,766 +9%
Credit Agricole
131
Credit Agricole
France
$665K -$400K -12,478 -39%
1GA
132
1st Global Advisors
Texas
$637K -$25.9K -809 -4%
Truist Financial
133
Truist Financial
North Carolina
$636K -$63.7K -1,990 -10%
Federated Hermes
134
Federated Hermes
Pennsylvania
$634K -$4.01M -125,200 -87%
BCMU
135
BlueCrest Capital Management (UK)
Guernsey
$585K +$553K +17,270 New
U
136
UBS
Switzerland
$551K +$6.02K +188 +1%
ST
137
Smithfield Trust
Pennsylvania
$549K +$519K +16,190 New
GCP
138
GSA Capital Partners
United Kingdom
$523K -$600K -18,732 -55%
CSS
139
Cubist Systematic Strategies
Connecticut
$486K +$460K +14,349 New
SM
140
Southport Management
Wyoming
$468K +$442K +13,800 New
MERSOM
141
Municipal Employees' Retirement System of Michigan
Michigan
$434K +$9.61K +300 +2%
PA
142
Profund Advisors
Maryland
$430K -$26K -813 -6%
Two Sigma Investments
143
Two Sigma Investments
New York
$405K -$470K -14,678 -55%
TD Asset Management
144
TD Asset Management
Ontario, Canada
$386K
Connor, Clark & Lunn Investment Management (CC&L)
145
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$365K -$785K -24,500 -71%
AL
146
Airain Ltd
Guernsey
$298K +$281K +8,788 New
OA
147
OFI Advisors
Pennsylvania
$285K -$29.7K -926 -10%
ZIM
148
Zacks Investment Management
Illinois
$280K +$265K +8,276 New
PI
149
PineBridge Investments
New York
$272K -$158K -4,935 -38%
PI
150
Placemark Investments
Illinois
$267K +$255K +7,961 New

PBH Hedge Fund Activity: Q2 2014 in Review

183 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2014, worth a combined $1.82B — up 27% from $1.43B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new PBH positions and 17 closed out — a net gain of 15 holders — while 65 added to existing stakes and 68 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $25.6M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $31.6M.

  • 183 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2014, up from 168 in Q1 2014.
  • Funds reported $1.82B of Prestige Consumer Healthcare stock for Q2 2014, up 27% quarter-over-quarter.
  • 32 funds opened new Prestige Consumer Healthcare positions in Q2 2014 and 17 closed out, a net change of +15 holders.
  • The largest Prestige Consumer Healthcare buyer in Q2 2014 was Fidelity Investments, an estimated $25.6M added.
  • The largest Prestige Consumer Healthcare seller in Q2 2014 was Columbia Wanger Asset Management, an estimated $31.6M sold.

Based on aggregated 13F filings for Q2 2014.